Repeated but Not Single Administration of Ketamine Prolongs Increases of the Firing Activity of Norepinephrine and Dopamine Neurons

Int J Neuropsychopharmacol. 2021 Jul 23;24(7):570-579. doi: 10.1093/ijnp/pyab010.

Abstract

Background: Clinical studies have shown that the rapid antidepressant effect of the glutamate N-methyl-D-aspartate receptor antagonist ketamine generally disappears within 1 week but can be maintained by repeated administration. Preclinical studies showed that a single ketamine injection immediately increases the firing and burst activity of norepinephrine (NE) neurons, but not that of serotonin (5-HT) neurons. It also enhances the population activity of dopamine (DA) neurons. In the present study, we investigated whether such alterations of monoamine neuronal firing are still present 1 day after a single injection, and whether they can be maintained by repeated injections.

Methods: Rats received a single ketamine injection or 6 over 2 weeks and the firing activity of dorsal raphe nucleus 5-HT, locus coeruleus NE, and ventral tegmental area DA neurons was assessed.

Results: One day following a single injection of ketamine, there was no change in the firing activity of 5-HT, NE, or DA neurons. One day after repeated ketamine administration, however, there was a robust increase of the firing activity of NE neurons and an enhancement of burst and population activities of DA neurons, but still no change in firing parameters of 5-HT neurons. The increased activity of NE neurons was no longer present 3 days after the last injection, whereas that of DA neurons was still present. DA neurons were firing normally 7 days after repeated injections.

Conclusion: These results imply that the enhanced activity of NE and DA neurons may play a significant role in the maintenance of the antidepressant action of ketamine.

Keywords: depression; dopamine; electrophysiology; ketamine; norepinephrine; serotonin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Adrenergic Neurons / drug effects*
  • Animals
  • Dopaminergic Neurons / drug effects*
  • Excitatory Amino Acid Antagonists / administration & dosage
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Ketamine / administration & dosage
  • Ketamine / pharmacology*
  • Locus Coeruleus / drug effects
  • Male
  • Raphe Nuclei / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Serotonergic Neurons / drug effects
  • Tegmentum Mesencephali / drug effects*
  • Ventral Tegmental Area / drug effects

Substances

  • Excitatory Amino Acid Antagonists
  • Ketamine

Grants and funding